Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder

ABSTRACT: Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder

PROVIDER: PRJNA1222986 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder

Project description:BBN is a bladder specific carcinogen that can cause invasive bladder cancer in mice possessing similar genetic alterations as seen in human cancer. We employed a single cell sequencing approach using 10x Genomics scRNAseq to investigate the cellular heterogeneity and molecular modifications induced by long term treatment with a carcinogen (BBN) on the bladder urothelium and sub-urothelium cells. Our data show infiltrations of B- and T-cells in the tumor and decrease of the several other urothelial populations.

2025-02-25 | GSE289453 | GEO

Epigenetic enhancer changes during oncogenic transformation

Project description:Epigenetic enhancer changes during oncogenic transformation

| PRJNA393898 | ENA

Kim et al. STRIPAK directs PP2A activity towards MAP4K4 to promote oncogenic transformation

Project description:STRIPAK directs PP2A activity towards MAP4K4 to promote oncogenic transformation

2019-10-04 | MSV000084422 | MassIVE

A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation

Project description:Data supporting the manuscript: A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation

2024-11-05 | MSV000096296 | MassIVE

Epigenetic enhancer changes during oncogenic transformation [ChIP-seq]

Project description:Identification of differential enhancers active during oncogenic transformation, using FAIRE-seq and ChIP-seq for H3K4me1 and H3K27ac

2020-07-11 | GSE101170 | GEO

STRIPAK directs PP2A activity to promote oncogenic transformation

Project description:STRIPAK directs PP2A activity to promote oncogenic transformation

| PRJNA485011 | ENA

METTL1-mediated m7G tRNA modification drives oncogenic transformation

Project description:METTL1-mediated m7G tRNA modification drives oncogenic transformation

| PRJNA631030 | ENA

Epigenetic enhancer changes during oncogenic transformation [RNA-seq]

Project description:Identification of differential enhancers active during oncogenic transformation, using RNA-seq with FAIRE-seq and ChIP-seq for H3K4me1 and H3K27ac.

2020-07-11 | GSE101241 | GEO

Gut microbiota carcinogen metabolism causes distal tissue tumours

Project description:<p>Exposure to environmental pollutants and human microbiome composition are important predisposition factors for tumour development. Similar to drug molecules, pollutants are typically metabolised in the body, which can change their carcinogenic potential and impact tissue distribution through altered toxicokinetics. Although recent studies demonstrated that human-associated microbes can chemically convert a wide range of xenobiotics and influence the profile and tissue exposure of resulting metabolites, the effect of microbial biotransformation on chemical-induced tumour development remains unclear. Here we show that the depletion of the gut microbiota dramatically reduces the development and severity of nitrosamine-induced urinary bladder cancer in mice, which affects the toxicokinetics of nitrosamines. We causally linked this carcinogen biotransformation to specific gut bacterial isolates in vitro and in vivo using individualized bacterial culture collections and gnotobiotic mouse models, respectively. We tested gut communities from different human donors to demonstrate that microbial carcinogen metabolism varies between individuals and we showed that this metabolic activity applies to structurally related nitrosamine-carcinogens. Altogether, these results suggest gut microbiota carcinogen metabolism as a contributing factor for chemical-induced carcinogenesis, which could open avenues to target the microbiome for improved predisposition risk assessment and prevention of cancer.</p>

2024-06-05 | MTBLS3581 | MetaboLights

ADAT2/3 complex-deposited tRNA inosines drives oncogenic transformation

Project description:ADAT2/3 complex-deposited tRNA inosines drives oncogenic transformation

| PRJNA980179 | ENA